Comparison of fluorescence and chromogenic in situ hybridization for detection of HER-2/neu oncogene expression in breast cancer

被引:0
|
作者
Gupta, D
Middleton, LP
Whitaker, MJ
Abrams, J
机构
[1] Univ Texas, Sch Med, Houston, TX USA
[2] St Lukes Episcopal Hosp, Houston, TX 77030 USA
[3] Texas Heart Inst, Houston, TX 77025 USA
[4] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1475
引用
收藏
页码:322A / 322A
页数:1
相关论文
共 50 条
  • [1] Comparison of fluorescence and chromogenic in situ hybridization for detection of HER-2/neu oncogene expression in breast cancer
    Gupta, D
    Middleton, LP
    Whitaker, MJ
    Abrams, J
    [J]. MODERN PATHOLOGY, 2003, 16 (01) : 322A - 322A
  • [2] Comparison of fluorescence and chromogenic in situ hybridization for detection of HER-2/neu oncogene in breast cancer
    Gupta, D
    Middleton, LP
    Whitaker, MJ
    Abrams, J
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 119 (03) : 381 - 387
  • [3] Chromogenic in situ hybridization for Her-2/neu-oncogene in breast cancer: comparison of a new dual-colour chromogenic in situ hybridization with immunohistochemistry and fluorescence in situ hybridization
    Mayr, Doris
    Heim, Sibylle
    Weyrauch, Kerstin
    Zeindl-Eberhart, Evelyn
    Kunz, Anne
    Engel, Jutta
    Kirchner, Thomas
    [J]. HISTOPATHOLOGY, 2009, 55 (06) : 716 - 723
  • [4] Detection of Her-2/neu oncogene in breast carcinoma by chromogenic in situ hybridization in cytologic specimens
    Lin, F
    Shen, T
    Prichard, JW
    [J]. DIAGNOSTIC CYTOPATHOLOGY, 2005, 33 (06) : 376 - 380
  • [5] Chromogenic in situ hybridization -: A practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples
    Tanner, M
    Gancberg, D
    Di Leo, A
    Larsimont, D
    Rouas, G
    Piccart, MJ
    Isola, J
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (05): : 1467 - 1472
  • [6] Comparison of HER-2/neu oncogene amplification detected by fluorescence in situ hybridization in lobular and ductal breast cancer
    Rosenthal, SI
    Depowski, PL
    Sheehan, CE
    Ross, JS
    [J]. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2002, 10 (01): : 40 - 46
  • [7] Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer
    Jacobs, TW
    Gown, AM
    Yaziji, H
    Barnes, MJ
    Schnitt, SJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) : 1974 - 1982
  • [8] Interlaboratory comparison of HER-2 oncogene amplification as detected by chromogenic and fluorescence in situ hybridization
    Isola, J
    Tanner, M
    Forsyth, A
    Cooke, TG
    Watters, AD
    Bartlett, JMS
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (14) : 4793 - 4798
  • [9] Her-2/neu Oncogene Amplification by Fluorescence In Situ Hybridization and Protein Overexpression on Immunohistochemistry in Breast Cancer
    Lateef, Fouzia
    Jamal, Saba
    Nasir, Surrayya
    [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2018, 28 (08): : 581 - 585
  • [10] Evaluation of HER-2/neu gene status in breast cancer by chromogenic in situ hybridization: Comparison with immunohistochemistry
    Kounelis, S
    Kapranos, N
    Malamos, N
    Kokka, E
    Arvanitis, H
    Kouri, E
    [J]. LABORATORY INVESTIGATION, 2003, 83 (01) : 37A - 37A